Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Minute Insights Commercial Companies

Minute Insight: Illumina Is Doing Stuff Again – More Leadership Changes

  • News

Executive Summary

The sequencing technology company, led by an interim CEO, is further shuffling its leadership following the announcement of disappointing mid-year results.

You may also be interested in...



Spinning Around – One Company's Bid To Diagnostic-ify The Metabolism

Lifespin is working on tools to characterize a patient’s metabolism and provide more detailed information about a disease.

PacBio Scores Hat Trick Of Big News To Start August

A jump in earnings, the acquisition of Apton and the launch of the long-awaited Onso sequencing system – all in one week at Pacific Biosciences.

More Kerfuffle At Illumina. This Time, It Is Job Cuts

The company is shrinking its work force and real estate footprint in a bid to save money.

Table

View full table

Topics

Related Companies

Tags:
Minute Insights Commercial Companies
Latest Headlines

Minute Insight: Maestro Cues The Music With CE Mark For Moon Surgical

Boston Scientific Puts Charge In Neuromodulation Business By Acquiring Relievant

Optimizing EU Medtech Regulatory Governance And Innovation: First Workshop Shapes Future Study

Minute Insight: 15,000 Surgeries And More Funding For CMR Surgical

See All
UsernamePublicRestriction

Register

MT148173

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By